Executive team

Agustin Fernandez

Chief Executive Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB

Chief Regulatory & IP Officer

Edward Gershburg, PhD

Chief Technology Officer

Luis Rios-Nogales, MD, PhD, MBA

Chief Development and Medical Officer

Aziz Friedrich

Chief Financial Officer & Vice President of Operations

Gerhard Hager, PhD

Head of Non-Clinical Development

Kerstin Westritschnig, MD

Head of Clinical Development

Konstantin Kousoulas PhD

VP of Scientific Affairs

Cecilia Huaman, MPH, Ph.D

Director Immunology and Diagnostics

Brandie Murphy

Lab Manager

Bob Lemon, B.S., MBA

CMC Project Manager

Quinn Steele

Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq

Patient Advocate

Christy Mazzarisi

Vice President, Corporate Quality

Scientific Advisory Board

Paul Predki, PhD

SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA

Operating Partner, Flagship Pioneering

Lional Raj, MD

Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics

Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Todd Margolis, MD, PhD

Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS

Industry Consultant

David I. Bernstein, MD, MA

Professor of Pediatric Infectious Diseases at Cincinnati Children’s Hospital Medical Center

Stanley A. Plotkin, MD

Emeritus Professor at the University of Pennsylvania

Alan Kimura, MD, PhD

SVP & Therapeutic Area Head for Rare Diseases at CureVac